Project Grant R01DA063609
- Federal Grant Award Summary Arizona State University received a $650,613 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), awarded May 11, 2026, with completion targeted for January 31, 2031. The award funds a longitudinal research study examining within-person risk and protective factors for sexually aggressive behavior (SAB) in college men. The research disaggregates between-person and within-person risk factors...
- Federal Grant Award Summary Arizona State University received a $730,989 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 1, 2026 through May 31, 2028. The project, titled "Caring for the Caregivers: A Community-Developed Program to Prevent Substance Use for Children with Incarcerated Parents," will develop and adapt an evidence-based parenting program specifically tailored to address...
- Federal Grant Award Summary Arizona State University received a $193,958 Project Grant award dated May 15, 2026, from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods, community-engaged study examining the role of family and household members in reducing opioid overdose deaths. The research addresses critical gaps in the literature by investigating household and family-level protective factors associated...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $439,500 Project Grant to the University of California, San Diego to develop and validate a novel research paradigm for studying family dynamics in adolescent substance use. The 24-month award, initiated March 1, 2026 and concluding February 29, 2028, supports the creation of real-time, real-world intensive longitudinal data collection methods...
- Federal Project Grant Award Summary The University of Oregon received a $731,194 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 15, 2026, with completion by February 28, 2031. This research initiative addresses simultaneous alcohol and cannabis use (SAM) among young adults aged 18-25 through development and testing of a mobile application-based just-in-time intervention (JIT). The project will...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Oregon a Project Grant (R21) totaling $407,812 on September 10, 2025, under the Alcohol Research Programs (CFDA 93.273) to investigate dynamic associations between impulsivity, craving, and the concurrent use of alcohol, cannabis, and nicotine among young adults. The research addresses a critical public health gap, as dual- and tri-use of these substances is prevalent and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of California, Los Angeles a $376,398 Project Grant effective April 15, 2026, through February 28, 2029, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports the development and preliminary evaluation of a digital therapeutic intervention titled Anxiety Management Treatment for Substance Use Disorders (AMT/SUD), designed to address the clinical gap in treating patients...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Vermont & State Agricultural College a $387,291 Project Grant effective March 1, 2026, through December 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative delivers a comprehensive neuroimaging analysis examining developmental vulnerability windows for cannabis exposure and its causal relationships to neurodevelopment and behavioral outcomes....
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston University Medical Campus a Project Grant of $732,747 under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2026, with an ultimate completion date of March 31, 2031. This award supports research quantifying the health effects of cannabis use and cannabis use disorder (CUD) on geriatric syndromes and HIV outcomes through causal effects analysis. The research utilizes...
The National Institute on Drug Abuse (NIDA) awarded Arizona State University a $691,107 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2026, and concluding March 31, 2031. This research initiative investigates the predictors and acute outcomes of simultaneous cannabis and alcohol use among emerging adults in daily life. The study will employ Ecological Momentary Assessment (EMA) methodology with 300 participants engaging in regular simultaneous use, utilizing two 28-day data collection bursts at baseline and one-year follow-up. Participants will complete event-contingent reports documenting alcohol and cannabis use initiation, timing, and quantity, supplemented by daily prompts and acute follow-up assessments to capture real-time contextual information surrounding simultaneous use episodes. The primary deliverables include empirical characterization of simultaneous use patterns most strongly associated with acute negative consequences based on substance ordering, timing, and quantity; identification of early-episode markers predictive of harmful outcomes; and evidence to inform the development and timing of just-in-time interventions for individuals engaged in simultaneous substance use in naturalistic settings. This research addresses a critical public health gap by examining the complex acute processes preceding, during, and following simultaneous use events—information essential for optimizing intervention strategies targeting this high-risk emerging adult population with prevalence rates approaching one in four individuals.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $691.1k | 5/29/26 |